Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Riluzole

A benzothiazole drug that dampens the effects of glutamate on nerve cells: approved in the United States in 1995, it was the first medicine authorised for amyotrophic lateral sclerosis (ALS). This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.

Did you know?In the United States it remained the only approved medicine for ALS for more than twenty years, until edaravone arrived in 2017.

RiluzoleGo to the active ingredient →
RiluzoleActive ingredientRiluzoleCat. No. P-R060-001CAS 1744-22-5

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.